North Texas Angel Network

The North Texas Angel Network, established in 2008 and based in Dallas, Texas, focuses on investing in early-stage companies with promising products and potential for growth. Comprising over sixty successful entrepreneurs and business professionals, the network not only provides essential investment funds but also offers valuable experience and expertise to help these companies succeed. The group's commitment to innovation drives its investment strategy, making it a significant player in the support and development of emerging businesses in the region.

Mike Bartlett

Co-Founder and Chairman

8 past transactions

One Health Group

Seed Round in 2024
One Health Group develops a health assessment platform that uses intelligent sensors and artificial intelligence for health information. One Health Group supports an innovative network and culture. For the benefit of health and wellness in the future, they are dedicated to developing and implementing new technologies.

PodUp

Pre Seed Round in 2024
PodUp is a platform that simplifies podcast creation, production, and monetization. It equips users with integrated tools to enhance productivity and elevate podcasting experiences, enabling influencers and businesses to expand their audience and boost earnings.

Gardenuity

Seed Round in 2023
Gardenuity is an e-commerce startup focused on making gardening accessible to a broad audience. It offers a variety of home gardening products, including natural, non-genetically modified organism components. The company provides customized gardening solutions tailored to fit individual landscapes, delivering live plants and seeds suitable for both indoor and outdoor cultivation. By catering to gardening enthusiasts and landscape specialists, Gardenuity aims to enhance the gardening experience with a selection of unique decor and garden accessories.

Tella Firma

Angel Round in 2015
Tella Firma, LLC, founded in 2015 and based in Richardson, Texas, specializes in solid earth foundation solutions for the luxury custom home, multifamily, commercial office, and warehouse markets. The company has developed an innovative construction foundation system aimed at enhancing the way foundations are built in Texas. Its technology focuses on protecting buildings from damage caused by active soil movement, employing a field-tested method that elevates slab-on-grade foundations using piers. This process creates a protective void between the ground and the foundation, thereby safeguarding structures against risks associated with active clay soils and seismic activity.

Retrotope

Series B in 2015
Retrotope Inc. is a pharmaceutical company focused on developing therapeutics for degenerative diseases, particularly those affecting mitochondrial health. Founded in 2006 and based in Los Altos, California, Retrotope specializes in addressing conditions such as Parkinson's disease, Alzheimer's disease, mitochondrial myopathies, and retinopathies. The company is known for its drug RT001, which targets infantile neuroaxonal dystrophy, and it employs a unique drug platform that utilizes isotope effects to mitigate oxidative stress and cellular damage. Through several discovery and development programs, Retrotope aims to create innovative solutions for a range of neurological disorders, including Friedreich's ataxia, while also contributing to the broader understanding of metabolic processes related to these conditions.

AdBm Technologies

Series A in 2014
AdBm Technologies is an acoustical engineering firm based in Austin, Texas, established in 2012. The company specializes in creating innovative noise abatement solutions tailored for marine environments. By utilizing large arrays of Helmholtz resonators tuned to specific frequencies, AdBm Technologies effectively captures and mitigates noise generated by various industrial operations at sea. This technology aims to safeguard marine wildlife from the harmful impacts of underwater noise pollution, positioning the company at the intersection of environmental engineering, marine technology, and mechanical engineering.

Vital Art and Science

Series A in 2013
Vital Art and Science, LLC is an ophthalmic medical device company based in Dallas, Texas, founded in 2006. The company has developed myVisionTrack, a handheld application that allows patients with age-related macular degeneration and diabetic retinopathy to test and monitor their retinal function from the comfort of their homes. This user-friendly and accurate home diagnostic system empowers individuals to efficiently manage their vision health, facilitating timely monitoring of their conditions.

Carnegie Speech

Series A in 2007
Carnegie Speech Company, Inc. specializes in developing software designed to assess and enhance spoken language skills for both individuals and enterprises. Founded in 2001 and based in Pittsburgh, Pennsylvania, the company offers a range of products including the Carnegie Speech Assessment, which evaluates pronunciation, grammar, and fluency to assist organizations in making informed hiring decisions and measuring training effectiveness. Its NativeAccent software provides targeted pronunciation training, utilizing advanced technology to identify specific errors and demonstrate corrections through various media formats. Additionally, Carnegie Speech offers Climb Level 4, a training tool aimed at preparing international pilots and air traffic controllers for the ICAO aviation English test. The company serves diverse sectors, including business, aviation, government, healthcare, and education, delivering its products through resellers and an online platform. Its innovative approach leverages speech recognition and artificial intelligence to provide personalized and efficient language instruction.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.